Manufacturers Life Insurance Company, The Trevi Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 24,412 shares of TRVI stock, worth $153,551. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,412
Previous 23,431
4.19%
Holding current value
$153,551
Previous $99,000
54.55%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TRVI
# of Institutions
142Shares Held
85.3MCall Options Held
1.5MPut Options Held
304K-
Nea Management Company, LLC Timonium, MD11.4MShares$71.5 Million6.78% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$64.5 Million4.06% of portfolio
-
Rubric Capital Management LP New York, NY4.54MShares$28.5 Million0.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.84MShares$24.1 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.49MShares$21.9 Million5.95% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $367M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...